IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER

Sintilimab

Chinese Academy of Medical Sciencesmonoclonal_antibodyPhase 2Dormant

CCC

53/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 38/ 100
Competitive Position: 89/ 100

Competitive context

10 Active assets in the Sintilimab cohort.

Asset / Sponsor	Phase	Rating
Catequentinib Tang-Du Hospital	Phase 2	B
Thiotepa Zhejiang Cancer Hospital	Phase 2	CCC
Pirtobrutinib Zhejiang Cancer Hospital	Phase 2	CCC
(+)-VINCRISTINE Chinese Academy of Medical Sciences	Phase 2	CCC
S-1 Aiping Zhou	Phase 2	CCC

View all 13 →

Same molecule, other indications

IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:

Recurrent Adult Burkitt LymphomaDormant

BBB

Indicative ·

78 / 100

View asset →

Recurrent Adult Diffuse Small Cleaved Cell LymphomaDormant

BBB

Indicative ·

76 / 100

View asset →

lymphoblastic lymphomaDormant

BBB